HAGER INVESTMENT MANAGEMENT SERVICES, LLC

Position in EXEL — Exelixis, Inc.

CIK 2026645 NEW LONDON, NH

Position in EXEL

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$4,331

-$95 QoQ

Shares Held

101

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HAGER INVESTMENT MANAGEMENT SERVICES, LLC holds $2,309,604 across 5 Biotechnology names. EXEL ranks #4 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,089	$2,272,442
2	RLAY	Relay Therapeutics, Inc.	2,178	$21,671
3	PYXS	Pyxis Oncology, Inc.	5,000	$7,300
4	EXEL	Exelixis, Inc. This page	101	$4,331
5	ONC	BeOne Medicines Ltd.	13	$3,860

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,331	101	0.0%	Shares	Sole	2026-05-12
2025-12-31	$4,426	101	-80.7%	Shares	Sole	2026-01-22
2025-06-30	$23,009	522	—	Shares	Sole	2025-07-23
No filing history on record for this holder in this stock.